Cargando…
The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review
Since the World Health Organization (WHO) declared COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a pandemic in March 2020, and more than 117 million people worldwide have been confirmed to have been infected. Scientists, medical professionals, and o...
Autores principales: | Rizkita, Leonny Dwi, Astuti, Indwiani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989072/ https://www.ncbi.nlm.nih.gov/pubmed/33782640 http://dx.doi.org/10.1016/j.jpha.2021.03.003 |
Ejemplares similares
-
Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265–271]
por: Dwi Rizkita, Leonny, et al.
Publicado: (2022) -
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
por: Astuti, Indwiani, et al.
Publicado: (2020) -
miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia
por: Gunawan, Regina R, et al.
Publicado: (2023) -
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: O’Leary, Valerie Bríd, et al.
Publicado: (2020) -
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)